1528 related articles for article (PubMed ID: 8690523)
1. Predictors of late mortality in cutaneous malignant melanoma--a population-based study in Sweden.
Thörn M; Bergström R; Hedblad M; Lagerlöf B; Ringborg U; Adami HO
Int J Cancer; 1996 Jul; 67(1):38-44. PubMed ID: 8690523
[TBL] [Abstract][Full Text] [Related]
2. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
[TBL] [Abstract][Full Text] [Related]
3. Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Carstensen J; Hansson J
J Clin Oncol; 2014 May; 32(13):1356-64. PubMed ID: 24687828
[TBL] [Abstract][Full Text] [Related]
4. Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men.
Lyth J; Eriksson H; Hansson J; Ingvar C; Jansson M; Lapins J; Månsson-Brahme E; Naredi P; Stierner U; Ullenhag G; Carstensen J; Lindholm C
Br J Dermatol; 2015 Mar; 172(3):700-6. PubMed ID: 25323770
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based study.
Eriksson H; Frohm-Nilsson M; Järås J; Kanter-Lewensohn L; Kjellman P; Månsson-Brahme E; Vassilaki I; Hansson J
Br J Dermatol; 2015 Jan; 172(1):175-86. PubMed ID: 24910143
[TBL] [Abstract][Full Text] [Related]
6. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
7. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
Barnhill RL; Fine JA; Roush GC; Berwick M
Cancer; 1996 Aug; 78(3):427-32. PubMed ID: 8697387
[TBL] [Abstract][Full Text] [Related]
8. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
9. Reduced disease-specific survival following a diagnosis of multiple primary cutaneous malignant melanomas-a nationwide, population-based study.
Utjés D; Lyth J; Lapins J; Eriksson H
Int J Cancer; 2017 Dec; 141(11):2243-2252. PubMed ID: 28799271
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
[TBL] [Abstract][Full Text] [Related]
11. A prospective population-based study of cutaneous malignant melanoma of the head and neck.
Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
Laryngoscope; 2000 Sep; 110(9):1498-504. PubMed ID: 10983950
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
13. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
[TBL] [Abstract][Full Text] [Related]
15. Conditional survival after surgical treatment of melanoma: an analysis of the Surveillance, Epidemiology, and End Results database.
Rueth NM; Groth SS; Tuttle TM; Virnig BA; Al-Refaie WB; Habermann EB
Ann Surg Oncol; 2010 Jun; 17(6):1662-8. PubMed ID: 20165985
[TBL] [Abstract][Full Text] [Related]
16. Prognostic instrument for survival outcome in melanoma patients: based on data from the population-based Swedish Melanoma Register.
Lyth J; Mikiver R; Nielsen K; Isaksson K; Ingvar C
Eur J Cancer; 2016 May; 59():171-178. PubMed ID: 27046697
[TBL] [Abstract][Full Text] [Related]
17. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.
Blaheta HJ; Ellwanger U; Schittek B; Sotlar K; MacZey E; Breuninger H; Thelen MH; Bueltmann B; Rassner G; Garbe C
J Invest Dermatol; 2000 Apr; 114(4):637-42. PubMed ID: 10733666
[TBL] [Abstract][Full Text] [Related]
18. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
[TBL] [Abstract][Full Text] [Related]
19. Age as a key factor influencing metastasizing patterns and disease-specific survival after sentinel lymph node biopsy for cutaneous melanoma.
Kretschmer L; Starz H; Thoms KM; Satzger I; Völker B; Jung K; Mitteldorf C; Bader C; Siedlecki K; Kapp A; Bertsch HP; Gutzmer R
Int J Cancer; 2011 Sep; 129(6):1435-42. PubMed ID: 21064111
[TBL] [Abstract][Full Text] [Related]
20. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
